Tag: Next-generation Gallant
Abbott receives FDA approval for new heart rhythm devices
Abbott announced that the US Food and Drug Administration (FDA) has approved the company's next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy...